BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 24652715)

  • 1. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
    Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide.
    Xiong H; Guo Z; Zhang W; Zhong H; Liu S; Ji Y
    J Photochem Photobiol B; 2014 Sep; 138():191-201. PubMed ID: 24976623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy.
    Qin XC; Guo ZY; Liu ZM; Zhang W; Wan MM; Yang BW
    J Photochem Photobiol B; 2013 Mar; 120():156-62. PubMed ID: 23357205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
    Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
    Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.
    Zhang X; Yang C; Zhou J; Huo M
    Small; 2016 Jul; 12(26):3578-90. PubMed ID: 27244649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide.
    Zhang W; Guo Z; Huang D; Liu Z; Guo X; Zhong H
    Biomaterials; 2011 Nov; 32(33):8555-61. PubMed ID: 21839507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery.
    Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J
    J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel doxorubicin loaded PEGylated cuprous telluride nanocrystals for combined photothermal-chemo cancer treatment.
    Wang X; Ma Y; Chen H; Wu X; Qian H; Yang X; Zha Z
    Colloids Surf B Biointerfaces; 2017 Apr; 152():449-458. PubMed ID: 28187379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
    Bai J; Liu Y; Jiang X
    Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power.
    Yang K; Wan J; Zhang S; Tian B; Zhang Y; Liu Z
    Biomaterials; 2012 Mar; 33(7):2206-14. PubMed ID: 22169821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells.
    Jin R; Ji X; Yang Y; Wang H; Cao A
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):7181-9. PubMed ID: 23875578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
    Kim H; Lee D; Kim J; Kim TI; Kim WJ
    ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets.
    Masoudipour E; Kashanian S; Maleki N; Karamyan A; Omidfar K
    Drug Dev Ind Pharm; 2018 Jan; 44(1):99-108. PubMed ID: 28956455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
    Liu W; Zhang X; Zhou L; Shang L; Su Z
    J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug.
    Zhao X; Yang L; Li X; Jia X; Liu L; Zeng J; Guo J; Liu P
    Bioconjug Chem; 2015 Jan; 26(1):128-36. PubMed ID: 25525819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet.
    Vimala K; Shanthi K; Sundarraj S; Kannan S
    J Colloid Interface Sci; 2017 Feb; 488():92-108. PubMed ID: 27821343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile fabrication of a near-infrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer therapy.
    Wan H; Zhang Y; Liu Z; Xu G; Huang G; Ji Y; Xiong Z; Zhang Q; Dong J; Zhang W; Zou H
    Nanoscale; 2014 Aug; 6(15):8743-53. PubMed ID: 24954159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.